Biotech · Public company · South San Francisco, CA, US
Corvus Pharmaceuticals, Inc.
Ticker CRVS · SEC CIK 0001626971
Track this companyFree. Adds Corvus Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials104 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline16
- BelinostatPhase 3 · Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedClinicalTrials.gov · fetched Nov 12, 2026
- CPI-006 1 mg/kg + SOCPhase 3 · Covid-19ClinicalTrials.gov · fetched Nov 12, 2026
- CPI-006 2 mg/kg + SOCPhase 3 · Covid-19ClinicalTrials.gov · fetched Nov 12, 2026
- PralatrexatePhase 3 · Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedClinicalTrials.gov · fetched Nov 12, 2026
- SoquelitinibPhase 3 · Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedClinicalTrials.gov · fetched Nov 12, 2026
- SoquelitinibPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- CiforadenantPhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- CiforadenantPhase 1 · Renal Cell CancerClinicalTrials.gov · fetched Nov 12, 2026
- Ciforadenant + atezolizumabPhase 1 · Renal Cell CancerClinicalTrials.gov · fetched Nov 12, 2026
- CPI-006Phase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- CPI-006Phase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- CPI-006 + ciforadenantPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- CPI-006 + pembrolizumabPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- CPI-818Phase 1 · T-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- daratumumabPhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- SoquelitinibPhase 1 · Hidradenitis Suppurativa (HS)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Safety and Efficacy of Soquelitinib in Adults With Hidradenitis SuppurativaPHASE1 · RECRUITING · started Sep 17, 2026ClinicalTrials.gov NCT07828860 · fetched Nov 12, 2026
- Study to Evaluate Soquelitinib in Participants With Moderate to Severe ADPHASE2 · RECRUITING · started Feb 1, 2026ClinicalTrials.gov NCT07441395 · fetched Nov 12, 2026
- Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaPHASE3 · RECRUITING · started Oct 2, 2024ClinicalTrials.gov NCT06561048 · fetched Nov 12, 2026
- Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe ADPHASE1 · COMPLETED · started Apr 16, 2024ClinicalTrials.gov NCT06345404 · fetched Nov 12, 2026
- CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 PatientsPHASE3 · TERMINATED · started Feb 25, 2021ClinicalTrials.gov NCT04734873 · fetched Nov 12, 2026
- Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 PatientsPHASE1 · COMPLETED · started Jul 1, 2020ClinicalTrials.gov NCT04464395 · fetched Nov 12, 2026
- Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple MyelomaPHASE1 · COMPLETED · started Feb 20, 2020ClinicalTrials.gov NCT04280328 · fetched Nov 12, 2026
- A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell LymphomaPHASE1 · ACTIVE_NOT_RECRUITING · started May 3, 2019ClinicalTrials.gov NCT03952078 · fetched Nov 12, 2026
- CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersPHASE1 · COMPLETED · started Apr 25, 2018ClinicalTrials.gov NCT03454451 · fetched Nov 12, 2026
- Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced CancersPHASE1 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02655822 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 22, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 13, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 12, 2026 · fetched Nov 12, 2026